Odyssey Therapeutics

Masters of Drug Hunting: Making the Impossible Possible

Led by a team with an exceptional track record of success, we aim to deliver next generation precision medicines to patients with inflammatory diseases and cancer. We are working with dedication and urgency, employing an integrated suite of cutting-edge technologies directed at molecular targets that hold the greatest promise to benefit patients.

Our team of drug hunters and academic founders are experts in the pathophysiology of inflammatory disorders and cancer. Odyssey is leveraging this in-house intellectual capital not only to select targets but also to determine the therapeutic modality that will have the greatest clinical impact: we can quickly identify relevant targets, devise pharmacological mechanisms of invention to reverse the disease biology, and optimize therapeutic assets for clinical development.

Our expertise, dedication, collaborative spirit, and teamwork have led us to this pivotal moment: coming together to disrupt the trajectory of drug discovery and development and to go beyond the limitations of current medicines to make the future of precision medicine a reality.

Catalyzing a Path to the Future of Precision Medicine

Odyssey has developed a strategy to create a portfolio of medicines that will go beyond the boundaries of today’s drugs. By focusing on key signaling nodes that drive disease, we aim to achieve optimal product profiles and minimize attrition to maximize the potential clinical impact of each target.

Through our integrated drug discovery engine that fuses both established and newly-emerging drug discovery technologies, we are tackling targets that hold great promise for patients but are currently considered undruggable. By leveraging the synergy of foundational biology, technological innovation, data sciences, and our deep experience in drug discovery and development, Odyssey is making the promise of precision medicine a reality.